The market is paying for a Vans recovery that earnings have not yet shown. V.F. Corporation rose 13.57% in a week, and what separates it from the other three is an identifiable trigger: JPMorgan upgraded the shares to neutral on October 9, 2026, then …
Short interest is shares sold short divided by the shares available to trade, and days to cover divides the same position by average daily volume. Ondas leads on the first measure and ranks second lowest on the second, so a squeeze would be quick …
SoundHound is the only name here with revenue growth that the market already treats as proven, and shorts are betting on the price anyway. What separates it is scale: second quarter revenue of USD 61.9 million rose 45%, and 2026 guidance was raised to …
A short position into an FDA date is a bet that approval is priced in or that the market sells the news. What separates Intellia is the longest runway to a decision: March 10, 2027 is 145 days away, own arithmetic from October 16, …
FuelCell is a pre-scale manufacturer financed by equity, and shorts added after a documented miss. What separates it from the other three is that the pressure in the filings reviewed is dilution and production, not debt. Shares short rose 23.89% to 24,900,440 between August …
A bitcoin miner is being repriced as a leveraged data center developer, and the quote shows it. CleanSpark (NASDAQ:CLSK) traded at USD 8.96 on October 16, 2026, down 4.12%, for a market capitalisation of USD 2.30 billion and 27.1% below its USD 12.29 close …
One share in four is sold short ahead of a binary data event. Tango Therapeutics (NASDAQ:TNGX) quoted USD 22.66 on October 16, 2026, down 0.20%, for a USD 3.82 billion market capitalisation, with no company-specific catalyst identified for the session. Days to cover of …
The market is asking whether an AI lending platform can grow without holding credit risk. Upstart (NASDAQ:UPST) quoted USD 24.54 on October 16, 2026, down 0.85%, for a USD 2.39 billion market capitalisation. No company-specific catalyst was identified in the filings and releases reviewed …
The market traded outbreak headlines, though the company has no plague vaccine. Novavax (NASDAQ:NVAX) rose 20.08% on October 5, 2026, to USD 12.56 as shorts covered after a Vaxcyte late-stage pneumonia vaccine result and unconfirmed reports of a suspected plague case in Russia. The …
The data event is seven days away, and one share in four is sold short. Tango Therapeutics (NASDAQ:TNGX) quoted USD 22.66 on October 16, 2026, down 0.20%, for a USD 3.82 billion market capitalisation, with no company-specific catalyst identified for the session. The June …